64Cu-DOTA-ECL1i

DRUG4 trials

Sponsors

Washington University School of Medicine, University of Pennsylvania

Conditions

Abdominal Aortic AneurysmHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Head and Neck Squamous Cell Carcinoma HNSCCHeart Diseases

Phase 1

Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer

TerminatedNCT04217057

Washington University School of MedicineHead and Neck Cancer

Start: 2020-02-07End: 2023-02-07Updated: 2024-11-19

Evaluation of CCR2 in Patients Post Myocardial Infarction

Washington University School of MedicineHeart Diseases

Start: 2018-11-24End: 2025-11-24Target: 90Updated: 2022-11-23

Phase 2

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

Not yet recruitingNCT07659678

Washington University School of MedicineHead and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma HNSCC, Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)

Start: 2026-08-31End: 2032-03-31Target: 90Updated: 2026-06-22

Unknown Phase

Molecular Imaging of the Underlying Mechanism of Vessel Wall Inflammation Using Positron Emission Tomography (PET/CT)

RecruitingNCT07548099

University of PennsylvaniaAbdominal Aortic Aneurysm

Start: 2026-04-30End: 2029-04-30Target: 30Updated: 2026-05-22